1 year return (CAGR)
36.16%
Celldex Therapeutics Inc Exchange (NASDAQ, USD)
CLDX
31.10
-4.38 (-11.56%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
6.23%
5 year return (CAGR)
-8.86%
10 year return (CAGR)
-4.95%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
2.63B
Price/Sales
23495.76
Ent value
2.65B
Price/Book
3.68
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
14.05%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 36.60 |
| Daily high | 38.39 |
| Daily low | 30.39 |
| Daily Volume | 12.9M |
| All-time high | 3015.00 |
| 1y analyst estimate | 58.07 |
| Beta | 0.84 |
| EPS (TTM) | -3.86 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 2 Mar 2026 |
Downside potential
Loading...
Downside potential data
| CLDX | S&P500 | |
| Current price drop from All-time high | -98.97% | -0.84% |
| Highest price drop | -99.95% | -56.47% |
| Date of highest drop | 20 Mar 2020 | 9 Mar 2009 |
| Avg drop from high | -84.55% | -10.68% |
| Avg time to new high | 264 days | 12 days |
| Max time to new high | 6677 days | 1805 days |
News
